New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 10, 2009
08:31 EDTCVS
theflyonthewall.com: CVS Caremark, Generation Health form strategic partnership
CVS Caremark and Generation Health, a genetic benefit management company, announced a strategic partnership to expand pharmacogenomic clinical and testing services for CVS Caremark pharmacy benefit management clients to improve care for patients who either are non-responsive or have adverse reactions to their medications. :theflyonthewall.com



News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
There are 28 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2012
10:32 EDTCVS
theflyonthewall.com: On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Diamond Foods (DMND) downgraded to Neutral from Buy at SunTrust...3M Company (MMM) downgraded to Hold from Buy at Deutsche Bank...Sohu.com (SOHU) downgraded to Hold from Buy at Deutsche Bank...Amgen (AMGN) downgraded to Perform from Outperform at Oppenheimer...A123 Systems (AONE) downgraded to Sell from Hold at Wunderlich...iRobot (IRBT) downgraded to Underweight from Neutral at JP Morgan...Federated Investors (FII) downgraded to Underperform from Neutral at Macquarie...CVS Caremark (CVS) downgraded to Neutral from Outperform at Macquarie...DirecTV (DTV) downgraded to Neutral from Outperform at Macquarie...Wright Express (WXS) downgraded to Neutral from Buy at Janney Capital...Boyd Gaming (BYD) downgraded to Equal Weight from Overweight at Barclays...Joy Global (JOYG) downgraded to Hold from Buy at Jefferies...DuPont Fabros (DFT) downgraded to Hold from Buy at Jefferies...DuPont Fabros downgraded to Market Perform from Outperform at Wells Fargo...TripAdvisor (TRIP) downgraded to Hold from Buy at Benchmark Co. :theflyonthewall.com
06:36 EDTCVS
theflyonthewall.com: CVS Caremark downgraded to Neutral from Outperform at Macquarie

Subscribe for More Information
:theflyonthewall.com
06:12 EDTCVS
theflyonthewall.com: CVS Caremark price target raised to $50 from $46 at Barclays

Subscribe for More Information
:theflyonthewall.com

February 8, 2012
12:13 EDTCVS
theflyonthewall.com: On The Fly: Mid-Day Wrap
Stocks on Wall Street were lower at mid-day, as a rally that has extended through most sessions this year took a pause. Each of the major indices has moved into negative territory. The averages hung around the flat line for most of the early morning, as the absence of any major news kept the market from establishing a firm direction. In the end, the absence of news sent the averages into negative territory, as the wait for a deal between Greece and the EU has left investors frustrated and on the sideline... ECONOMIC EVENTS: Domestically, the MBA Mortgage Applications Composite Index was up 7.5% for the week. Crude inventories rose by 304K barrels, less than the consensus forecast of a 2.5M barrel build. As for Europe, the Journal said the ECB is making concessions that will help Greece lower its debt burden, but investors still await the announcement of a deal that will secure Greece's next bailout payment... MARKET NEWS: Disney (DIS) shares rose as BMO Capital and Credit Suisse raised their price targets after the company's adjusted earnings beat estimates. Among other large cap companies reporting results, Cerner (CERN), Ralph Lauren (RL), and CVS Caremark (CVS) advanced, while Western Union (WU) and BHP Billiton (BHP) retreated... 3M (MMM) announced that Inge Thulin will take over as CEO when George Buckley retires... Shares of Caesar's Entertainment (CZR) traded actively after its IPO opened for trade at $9.06... MAJOR MOVERS: Among the notable gainers were CSC (CSC), Calix (CALX), and Buffalo Wild Wings (BWLD), after they each had upside earnings surprises. Noteworthy losers included Silicon Graphics (SGI), after its earnings and guidance severely disappointed, and Higher One (ONE), following downgrades at Craig-Hallum and Raymond James on its Q4 report... INDICES: Near noon, the Dow was down 36.33, or 0.28%, to 12,841.87; the Nasdaq was down 5.04, or 0.17%, to 2,899.04; and the S&P 500 was down 2.26, or 0.17%, to 1,344.79. :theflyonthewall.com
09:10 EDTCVS
theflyonthewall.com: CVS Caremark says sees stronger front store trends in Q1 vs. Q4

Subscribe for More Information
:theflyonthewall.com
09:08 EDTCVS
theflyonthewall.com: CVS Caremark says 2012 "off to a great start"

Subscribe for More Information
:theflyonthewall.com
08:48 EDTCVS
theflyonthewall.com: CVS Caremark says posting strong pharmacy comps at levels not seen in awhile
:theflyonthewall.com
08:46 EDTCVS
theflyonthewall.com: CVS Caremark says sees FY12 net revenue up 12%-13.5% vs. 2011
Consensus is $119.53B. :theflyonthewall.com
08:41 EDTCVS
theflyonthewall.com: CVS Caremark says quarterly dividend to increase 30% in 2012
:theflyonthewall.com
08:41 EDTCVS
theflyonthewall.com: CVS says gaining more than its fare share of Walgreens' Express Scripts business

Subscribe for More Information
:theflyonthewall.com
08:39 EDTCVS
theflyonthewall.com: CVS says boosting view for Q1, but not other quarters

Subscribe for More Information
:theflyonthewall.com
08:37 EDTCVS
theflyonthewall.com: CVS Caremark sees FY12 retail pharmacy revenue up 3%-4% vs. 2011

Subscribe for More Information
:theflyonthewall.com
08:35 EDTCVS
theflyonthewall.com: CVS Caremark says to allocate $3.8B to dividends, share repurchases in 2012

Subscribe for More Information
:theflyonthewall.com
08:32 EDTCVS
theflyonthewall.com: CVS Caremark says Christmas front-store sales "a bit lower" than planned

Subscribe for More Information
:theflyonthewall.com
08:31 EDTCVS
theflyonthewall.com: CVS Caremark says PBM business streamlining proceeding on track

Subscribe for More Information
:theflyonthewall.com
08:30 EDTCVS
theflyonthewall.com: CVS Caremark seeing "significant" number of scripts transfer from Walgreens

Subscribe for More Information
:theflyonthewall.com
07:24 EDTCVS
theflyonthewall.com: CVS CEO Merlo says gaining market share from Walgreen dispute

Subscribe for More Information
:theflyonthewall.com
07:16 EDTCVS
theflyonthewall.com: Walgreen feels deal with Express Scripts not in best interest, says Jefferies
Jefferies says Walgreens (WAG) indicated to the firm during a visit to the company's headquarters that coming to an agreement with Express Scripts (ESRX) is not in its best interest since the damage to its business has already been realized. Walgreens is very confident that Express Scripts will lose significant business as the 2013 selling season progresses, leading to business returning back to the company over the next 18 months, Jefferies added. Further, Jefferies states that Walgreen management feels that its partners Catalyst (CHSI) and MedImpact are likely to win significant business, as is CVS Caremark (CVS). :theflyonthewall.com
06:54 EDTCVS
theflyonthewall.com: CVS raises Q1/FY12 outlook; reflects anticipated benefit from WAG, ESRX impasse

Subscribe for More Information
:theflyonthewall.com
06:52 EDTCVS
theflyonthewall.com: CVS Caremark sees 2012 free cash flow from operations $6.2B-$6.4B

Subscribe for More Information
:theflyonthewall.com
06:50 EDTCVS
theflyonthewall.com: CVS Caremark sees 2012 adj EPS view to $3.18-$3.28 vs. consensus $3.24

Subscribe for More Information
:theflyonthewall.com
06:50 EDTCVS
theflyonthewall.com: CVS Caremark sees Q1 adjusted EPS 61c-63c vs. consensus 61c

Subscribe for More Information
:theflyonthewall.com
06:47 EDTCVS
theflyonthewall.com: CVS Caremark retail pharmacy segment SSS increased 2.5% in Q4

Subscribe for More Information
:theflyonthewall.com
06:46 EDTCVS
theflyonthewall.com: CVS Caremark reports Q4 EPS 89c vs. consensus 89c

Subscribe for More Information
:theflyonthewall.com

February 7, 2012
15:36 EDTCVS
theflyonthewall.com: CVS Caremark March volatility low Q4 and outlook

Subscribe for More Information
:theflyonthewall.com
15:14 EDTCVS
theflyonthewall.com: Companies reporting Before the Market Open on Wednesday, February 8

Subscribe for More Information
:theflyonthewall.com
09:07 EDTCVS
theflyonthewall.com: CVS Caremark added to Top Picks Live list at Citigroup
Citigroup added CVS Caremark to its Top Picks Live list ahead of the company's Q4 results on February 8 and raised its price target for shares to $51 from $45. Citi expects CVS will see incremental upside starting in Q4 as a result of the dispute between Walgreens and Express Scripts. :theflyonthewall.com
07:36 EDTCVS
theflyonthewall.com: Walgreen, CVS Caremark selling sperm-count test, Bloomberg reports
Drugstore chains Walgreen Co. (WAG) and CVS Caremark (CVS) are selling a fertility test for men, reports Bloomberg. In April, Walgreen’s 7,800 U.S. stores plan to start selling a test that determines if a man is producing enough sperm to get a woman pregnant. Walgreen and CVS have already started selling SpermCheck Fertility online. Reference Link :theflyonthewall.com